Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Year: 2014
Type: review
Abstract: Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival. Although generally well tolerated, a minority of patients discontinue therapy due to gastrointestinal and skin-related adverse events (AEs). This review summarizes recommendations based on existing guidelines, research evidence, and consensus opinions of expert authors, with the aim of providing practicing physicians with the specific clinical information needed to educate the patient and better manage pirfenidone-related AEs with continued pirfenidone treatment. The main recommendations to help prevent and/or mitigate gastrointestinal and skin-related AEs include taking pirfenidone during (or after) a meal, avoiding sun exposure, wearing protective clothing, and applying a broad-spectrum sunscreen with high ultraviolet (UV) A and UVB protection. These measures can help optimize AE management, which is key to maintaining patients on an optimal treatment dose.
Source: Advances in Therapy
Institutions: Ruhrlandklinik, University of Duisburg-Essen, Aarhus University Hospital, Lyon 1 Université, Hôpital Louis Pradel, Erasmus MC, Erasmus University Rotterdam, Mater Misericordiae University Hospital, Ninewells Hospital, King's College London, Uppsala University, Heidelberg University, Royal Brompton Hospital, Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro de Investigación Biomédica en Red, Karolinska University Hospital, Centre Hospitalier Interrégional Edith Cavell, University of Catania
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
OpenAlex ID: W2086655418
